Latest Breaking News On - Oswaldo cruz foundation fiocruz - Page 12 : vimarsana.com

Health impacts of smoke from fires in Amazon

Depending on the time of the year and where you go in the Amazon, you may see two very different types of “mist”. One is the morning mist, caused

COVID Passes, International Travel: COVID-19 Global Weekly Highlights

These are the global coronavirus stories you need to know about this week.

Brazil to contribute to research into new drug against COVID-19

BRASILIA. KAZINFORM The Oswaldo Cruz Foundation (Fiocruz) will be part of an international phase-three study into drug Molnupiravir, manufactured by pharmaceutical company MSD.

Brazil to contribute to research into new drug against COVID-19

BRASILIA. KAZINFORM - The Oswaldo Cruz Foundation (Fiocruz) will be part of an international phase-three study into drug Molnupiravir, manufactured by pharmaceutical company MSD. The goal is to ascertain its efficiency in preventing the spread and transmission of COVID-19 among people exposed to the coronavirus. The announcement was made Wednesday (Oct. 6) by Fiocruz, Agencia Brasil reports.

UNESCO, L'Oréal and ABC announce the seven laureates of the 2021 "For Women in Science" Programme in Brazil

Flu Vaccination, Ending Lockdown, Vaccine Production in Latin America: COVID-19 Global Weekly Highlights

Brazil's Munduruku Tribe Haunted by Mercury's Deadly Threat

The relaxing of environmental controls under President Jair Bolsonaro has emboldened thousands of miners to invade constitutionally protected indigenous lands in Brazil.

University of São Paulo: RT-LAMP test developed on the Pasteur-USP Scientific Platform identifies coronavirus in 30 minutes

Brazil's Munduruku tribe haunted by mercury's deadly threat | One America News Network

Brazil's Munduruku tribe haunted by mercury's deadly threat